Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is an aggressive cancer arising from the bile ducts with a need for earlier diagnosis and a greater range of treatment options. KRAS/NRAS mutations are common in ICC tumours and 6–32% of patients also have isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Helen, Kaisaki, Pamela J., Harvey, Joe, Giacopuzzi, Edoardo, Ferla, Matteo P., Pentony, Melissa M., Knight, Samantha J.L., Sharma, Ricky A., Taylor, Jenny C., McCullagh, James S.O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966597/
https://www.ncbi.nlm.nih.gov/pubmed/31795195
http://dx.doi.org/10.3390/cancers11121895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966597/
https://www.ncbi.nlm.nih.gov/pubmed/31795195
http://dx.doi.org/10.3390/cancers11121895

Ejemplares similares